[go: up one dir, main page]

TR200201245T2 - Oncolytic combinations for cancer treatment. - Google Patents

Oncolytic combinations for cancer treatment.

Info

Publication number
TR200201245T2
TR200201245T2 TR2002/01245T TR200201245T TR200201245T2 TR 200201245 T2 TR200201245 T2 TR 200201245T2 TR 2002/01245 T TR2002/01245 T TR 2002/01245T TR 200201245 T TR200201245 T TR 200201245T TR 200201245 T2 TR200201245 T2 TR 200201245T2
Authority
TR
Turkey
Prior art keywords
cancer treatment
oncolytic
combinations
oncolytic combinations
ltb4
Prior art date
Application number
TR2002/01245T
Other languages
Turkish (tr)
Inventor
Herbert Fleisch Jerome
Stuart Benjamin Roger
Scott Sawyer Jason
Ann Teicher Beverly
Wade Beight Douglas
C. R. Smith Edward
Thomas Mcmillen William
Original Assignee
Eli Lilly And Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly And Company filed Critical Eli Lilly And Company
Publication of TR200201245T2 publication Critical patent/TR200201245T2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)

Abstract

Lökotrien (LTB4) antagonistleri, 2', 2'-difloronükleosid kanser karsiti maddelerin etkililigini artirirlar.Leukotriene (LTB4) antagonists enhance the efficacy of 2 ', 2'-difluoronucleoside anti-cancer agents.

TR2002/01245T 1999-11-11 2000-11-09 Oncolytic combinations for cancer treatment. TR200201245T2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US16478699P 1999-11-11 1999-11-11

Publications (1)

Publication Number Publication Date
TR200201245T2 true TR200201245T2 (en) 2004-08-23

Family

ID=22596085

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2002/01245T TR200201245T2 (en) 1999-11-11 2000-11-09 Oncolytic combinations for cancer treatment.

Country Status (22)

Country Link
EP (1) EP1231938A2 (en)
JP (1) JP2003513916A (en)
KR (1) KR20020069512A (en)
CN (1) CN1390139A (en)
AR (1) AR032432A1 (en)
AU (1) AU778829B2 (en)
BR (1) BR0015490A (en)
CA (1) CA2391416A1 (en)
CZ (1) CZ20021551A3 (en)
EA (1) EA200200545A1 (en)
HK (1) HK1050132A1 (en)
HU (1) HUP0204449A3 (en)
IL (1) IL148579A0 (en)
MX (1) MXPA02004733A (en)
NO (1) NO20022245L (en)
NZ (1) NZ517667A (en)
PE (1) PE20010701A1 (en)
PL (1) PL355172A1 (en)
SK (1) SK6492002A3 (en)
TR (1) TR200201245T2 (en)
WO (1) WO2001034137A2 (en)
ZA (1) ZA200202822B (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001034198A2 (en) * 1999-11-11 2001-05-17 Eli Lilly And Company Oncolytic combinations for the treatment of cancer
WO2001034197A2 (en) * 1999-11-11 2001-05-17 Eli Lilly And Company Oncolytic combinations for the treatment of cancer
US6797723B1 (en) 1999-11-11 2004-09-28 Eli Lilly And Company Heterocycle substituted diphenyl leukotriene antagonists
JP2001247459A (en) 2000-03-03 2001-09-11 Oakland Uniservices Ltd Cancer combination therapy
BR0110473A (en) * 2000-05-09 2003-04-01 Univ Creighton Methods for proliferation inhibition and apoptosis induction in cancer cells
EP1311262A4 (en) 2000-07-28 2005-06-01 Cancer Rec Tech Ltd CANCER THERAPY THROUGH COMBINATION THERAPY
GB0121285D0 (en) 2001-09-03 2001-10-24 Cancer Res Ventures Ltd Anti-cancer combinations
GB2386836B (en) 2002-03-22 2006-07-26 Cancer Res Ventures Ltd Anti-cancer combinations
GB2394658A (en) 2002-11-01 2004-05-05 Cancer Rec Tech Ltd Oral anti-cancer composition
EP1745014B1 (en) 2004-05-05 2011-07-06 High Point Pharmaceuticals, LLC Novel compounds, their preparation and use
US7968723B2 (en) 2004-05-05 2011-06-28 High Point Pharmaceuticals, Llc Compounds, their preparation and use
CN1302782C (en) * 2005-01-17 2007-03-07 北京京卫燕康药物研究所有限公司 Jixitabing hydrochloride solution type injection agent
CA2613365C (en) 2005-06-30 2013-08-13 Novo-Nordisk A/S Phenoxy acetic acids as ppar delta activators
NZ568488A (en) 2005-12-22 2011-07-29 High Point Pharmaceuticals Llc Phenoxy acetic acids as PPAR delta activators
US7943612B2 (en) 2006-03-09 2011-05-17 High Point Pharmaceuticals, Llc Compounds that modulate PPAR activity, their preparation and use
WO2008044729A1 (en) 2006-10-12 2008-04-17 Institute Of Medicinal Molecular Design. Inc. Carboxylic acid derivative
US8633245B2 (en) 2008-04-11 2014-01-21 Institute Of Medicinal Molecular Design, Inc. PAI-1 inhibitor
WO2014060381A1 (en) 2012-10-18 2014-04-24 Bayer Cropscience Ag Heterocyclic compounds as pesticides
US20150284380A1 (en) 2012-10-31 2015-10-08 Bayer Cropscience Ag Novel heterocyclic compounds as pest control agents
CN103319466B (en) * 2013-07-04 2016-03-16 郑州大学 Containing the 1,2,3-triazoles-dithiocarbamates compound of tonka bean camphor parent nucleus, preparation method and application thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6034256A (en) * 1997-04-21 2000-03-07 G.D. Searle & Co. Substituted benzopyran derivatives for the treatment of inflammation

Also Published As

Publication number Publication date
CN1390139A (en) 2003-01-08
ZA200202822B (en) 2003-09-23
HK1050132A1 (en) 2003-06-13
AU778829B2 (en) 2004-12-23
EA200200545A1 (en) 2002-12-26
WO2001034137A3 (en) 2002-02-14
NO20022245L (en) 2002-07-09
CA2391416A1 (en) 2001-05-17
EP1231938A2 (en) 2002-08-21
IL148579A0 (en) 2002-09-12
HUP0204449A2 (en) 2003-04-28
PL355172A1 (en) 2004-04-05
CZ20021551A3 (en) 2003-02-12
SK6492002A3 (en) 2003-09-11
NO20022245D0 (en) 2002-05-10
WO2001034137A2 (en) 2001-05-17
HUP0204449A3 (en) 2006-02-28
MXPA02004733A (en) 2002-08-30
NZ517667A (en) 2004-05-28
AU1599001A (en) 2001-06-06
AR032432A1 (en) 2003-11-12
KR20020069512A (en) 2002-09-04
BR0015490A (en) 2002-07-09
PE20010701A1 (en) 2001-07-07
JP2003513916A (en) 2003-04-15

Similar Documents

Publication Publication Date Title
TR200201245T2 (en) Oncolytic combinations for cancer treatment.
BR0216099B1 (en) "WEAR SET".
PT960107E (en) 6-TIO-SUBSTITUTED PACLITAXEL COMPOUNDS
ATE293618T1 (en) 4, 5, 6, 7-TETRAHYDROINDAZOLE DERIVATIVES AS ANTI-TUMOR AGENTS
DE69925133D1 (en) PYRROLOBENZODIAZEPINE
TR200202194T2 (en) Polyglutamic acid-camptothecin compounds and preparation methods
ATE415979T1 (en) TREATMENT WITH ANTI-ERBB2 ANTIBODIES
TR199800436A3 (en) The use of primidine derivatives for cancer prevention.
ATE231872T1 (en) THIAZOLOPYRIMIDE DERIVATIVES
WO2001034198A3 (en) Oncolytic combinations for the treatment of cancer
DE60112960D1 (en) CONDENSED PYRIDOINDOL DERIVATIVES
TR199901017A2 (en) Insecticide composition.
DK1204659T3 (en) Serotonergic benzofurans
ITRM990426A0 (en) USE OF SUBSTANCE P INHIBITORS FOR THE TREATMENT OF ADENOCARCINOMAS.
DE60121048D1 (en) PYRAZINOi1'2 ': 1,6öPYRIDOi3,4-BöINDOLDERIVATE
TR200302134T4 (en) Use of 2-methyl-thiazolidine-2,4-dicarboxylic acid and / or physiologically acceptable salts thereof as anti-cancer agents.
WO2001034134A3 (en) Oncolytic combinations for the treatment of cancer
ITMI20001848A0 (en) DRUGS FOR INCONTINENCE.
NO20020914L (en) Alkoxy-substituted benzimidazole compounds, preparations containing them and their applications
ZA200205470B (en) Virus strains for the oncolytic treatment of cancer.
ATE250340T1 (en) 7-METHYLTHIOOXOMETHYL AND 7-METHYLTHIODIOXOMETHYL PACLITAXELE
ITTO20010222A1 (en) OLIVE TREATMENT MACHINE.
BR0008791A (en) Anticonvulsant derivatives, useful in treating essential tremor
TR200003084T2 (en) Paroxetine ascorbate
IT1320082B1 (en) PROCEDURE FOR THE CREATION OF BRA, AS WELL AS BRA 'OBTAINED.